Myocardial injury after non-cardiac surgery and per operative fibrin metabolism in patients undergoing hip-fracture surgery: an observational study

References

• Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372(9633):139–144.
   PubMed Web of Science ®Google Scholar
• Semel M, Lipsitz S, Funk L, et al. Rates and patterns of death after surgery in the United States, 1996 and 2006. Surgery. 2012;151(2):171–182.
   PubMed Web of Science ®Google Scholar
• Kristensen S, Knuuti J, Saraste A, et al. ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur J Anaesthesiol. 2014;31(10):517–573.
   PubMed Web of Science ®Google Scholar
• Botto F, Alonso-Coello P, Chan MTV, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120:564–578.
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Xavier D, Pogue J, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011;154(8):523–528.
   PubMed Web of Science ®Google Scholar
• Ekeloef S, Alamili M, Devereaux PJ, et al. Troponin elevations after non-cardiac, non-vascular surgery are predictive of major adverse cardiac events and mortality: a systematic review and meta-analysis. Br J Anaesth. 2016;117(5):559–568.
   PubMed Web of Science ®Google Scholar
• Hietala P, Strandberg M, Kiviniemi T, et al. Usefulness of troponin T to predict short-term and long-term mortality in patients after hip fracture. Am J Cardiol. 2014;114(2):193–197.
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Szczeklik W. Myocardial injury after non-cardiac surgery: diagnosis and management. Eur Heart J. 2020;41(32):3083–3091.
   PubMed Web of Science ®Google Scholar
• Sheth T, Natarajan MK, Hsieh V, et al. Incidence of thrombosis in perioperative and non-operative myocardial infarction. Br J Anaesth. 2018;120(4):725–733.
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Goldman L, Cook DJ, et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005;173(6):627–634.
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373(23):2258–2269.
   PubMed Web of Science ®Google Scholar
• Smilowitz NR, Redel-Traub G, Hausvater A, et al. Myocardial injury after non-cardiac surgery: a systematic review and meta-analysis. cardiol rev. 2019;27(6):267–273.
   PubMed Web of Science ®Google Scholar
• Górka J, Polok K, Iwaniec T, et al. Altered preoperative coagulation and fibrinolysis are associated with myocardial injury after non-cardiac surgery. Br J Anaesth. 2017;118(5):713–719.
   PubMed Web of Science ®Google Scholar
• Ekeloef S, Homilius M, Stilling M, et al. The effect of remote ischaemic preconditioning on myocardial injury in emergency hip fracture surgery (PIXIE trial): phase II randomised clinical trial. BMJ. 2019;367:l6395.
   PubMedGoogle Scholar
• Wahlstrøm KL, Ekeloef S, Sidelmann JJ, et al. Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial. Blood Coagul Fibrinolysis. 2022;33(1):25–33.
   PubMed Web of Science ®Google Scholar
• Ruetzler K, Smilowitz NR, Chair V, et al. Diagnosis and management of patients with myocardial injury after noncardiac surgery a scientific statement from the American heart association. Circ J. 2021;144:287–305.
   Google Scholar
• Gram AS, Bladbjerg EM, Skov J, et al. Three months of strictly controlled daily endurance exercise reduces thrombin generation and fibrinolytic risk markers in younger moderately overweight men. Eur J Appl Physiol. 2015;115(6):1331–1338.
   PubMed Web of Science ®Google Scholar
• Sjøland JA, Sidelmann JJ, Brabrand M, et al. Fibrin clot structure in patients with end-stage renal disease. Thromb Haemost. 2007;98(2):339–345.
   PubMed Web of Science ®Google Scholar
• Carr ME, Gabriel DA. The effect of dextran 70 on the structure of plasma-derived fibrin gels. J Lab Clin Med. 1980;96:985–993.
   PubMed Web of Science ®Google Scholar
• Carr ME, Hermans J. Size and density of fibrin fibers from turbidity. Macromolecules. 1978;11(1):46–50.
   PubMed Web of Science ®Google Scholar
• Haase C, Joergensen M, Ellervik C, et al. Age- and sex-dependent reference intervals for D-dimer: evidence for a marked increase by age. Thromb Res. 2013;132(6):676–680.
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Lowe GDO, Shaper AG, et al. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J. 2005;26(17):1765–1773.
   PubMed Web of Science ®Google Scholar
• Mukamal KJ, Jadhav PP, D'Agostino RB, et al. Alcohol consumption and hemostatic factors: analysis of the framingham offspring cohort. Circ J. 2001;104(12):1367–1373.
   Google Scholar
• Hatzinikolaou-Kotsakou E, Kartasis Z, Tziakas D, et al. Clotting state after cardioversion of atrial fibrillation: a haemostasis index could detect the relationship with the arrythmia duration. Thromb J. 2005;3(1):2.
   PubMedGoogle Scholar
• Catena C, Zingaro L, Casaccio D, et al. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med. 2000;109(7):556–561.
   PubMed Web of Science ®Google Scholar
• Prochaska JH, Frank B, Nagler M, et al. Age-related diagnostic value of D-dimer testing and the role of inflammation in patients with suspected deep vein thrombosis. Sci Rep. 2017;7(1):4591.
   PubMedGoogle Scholar
• Dindo D, Breitenstein S, Hahnloser D, et al. Kinetics of D-dimer after general surgery. Blood Coagul Fibrinolysis. 2009;20(5):347–352.
   PubMed Web of Science ®Google Scholar
• Capecchi M, Scalambrino E, Griffini S, et al. Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levels. Int J Lab Hematol. 2021;43(5):248–251.
   Web of Science ®Google Scholar
• Ay C, Vormittag R, Dunkler D, et al. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the vienna cancer and thrombosis study. J Clin Oncol. 2009;27(25):4124–4129.
   PubMed Web of Science ®Google Scholar
• Zeuthen EL, Lassen JF, Husted SE. Haemostatic activity in patients with atrial fibrillation treated with low-molecular-weight heparin before and after electrical cardioversion. J Thromb Thrombolysis. 2004;17(3):185–189.
   PubMed Web of Science ®Google Scholar
• Henareh L, Jogestrand T, Agewall S. Prothrombin fragment 1 + 2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction. Thromb Res. 2009;124(5):526–530.
   PubMed Web of Science ®Google Scholar
• Henareh L, Camilla J, Jogestrand T, et al. Intima-media thickness of common carotid and brachial arteries and prothrombin fragment 1 + 2 are associated with left ventricular diastolic dysfunction in patients with myocardial infarction. Echocardiography. 2010;27(6):651–658.
   PubMed Web of Science ®Google Scholar
• Su EP, Mount LE, Nocon AA, et al. Changes in markers of thrombin generation and interleukin-6 during unicondylar knee and total knee arthroplasty. J Arthroplasty. 2018;33(3):684–687.
   PubMed Web of Science ®Google Scholar
• Dexter SPL, Griffith JP, Grant PJ, et al. Activation of coagulation and fibrinolysis in open and laparoscopic cholecystectomy. Surg Endosc. 1996;10(11):1069–1074.
   PubMed Web of Science ®Google Scholar
• Bai F, Feng S, Xu C, et al. Transurethral resection versus holmium laser enucleation of the prostate: a prospective randomized trial comparing perioperative thrombin generation and fibrinolysis. Medicine (Baltimore)). 2019;98(15):e15223.
   PubMed Web of Science ®Google Scholar
• Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev. 2007;21(3):131–142.
   PubMed Web of Science ®Google Scholar
• Nickel CH, Kellett J, Cooksley T, et al. The diagnoses and outcomes of emergency patients with an elevated D-dimer over the next 90 days. Am J Med. 2021;134(2):260–266.e2.
   PubMed Web of Science ®Google Scholar
• Soomro AY, Guerchicoff A, Nichols DJ, et al. The current role and future prospects of D-dimer biomarker. Eur Heart J Cardiovasc Pharmacother. 2016;2(3):175–184.
   PubMed Web of Science ®Google Scholar
• Marumo M, Ekawa K, Ebara S, et al. Inverse association between habitual alcohol drinking and d-dimer in patients with type 2 diabetes mellitus. Alcohol. 2020;83:99–103.
   PubMed Web of Science ®Google Scholar
• Bao W, Qi X, Li HL, et al. Correlation of D-dimer level with the inflammatory conditions: a retrospective study. AME Med J. 2017;2:27–27.
   Google Scholar
• Ridker PM, Hennekens CH, Cerskus A, et al. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation. 1994;90(5):2236–2240.
   PubMed Web of Science ®Google Scholar
• Cushman M, Lemaitre RN, Kuller LH, et al. Fibrinolytic activation markers predict myocardial infarction in the elderly. The cardiovascular health study. Arterioscler Thromb Vasc Biol. 1999;19(3):493–498.
   PubMed Web of Science ®Google Scholar
• Liu C, Song Y, Zhao J, et al. Elevated D-dimer and fibrinogen levels in serum of preoperative bone fracture patients. Springerplus. 2016;5:161.
   PubMedGoogle Scholar
• Urano T, Suzuki Y, Iwaki T, et al. Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis. Curr Drug Targets. 2019;20(16):1695–1701.
   PubMed Web of Science ®Google Scholar
• Aillaud M, Juhan-Vague I, Alessi M, et al. Increased PA-inhibitor levels in the postoperative period–no cause-effect relation with increased cortisol. Thromb Haemost. 1985;54(2):466–468.
   PubMed Web of Science ®Google Scholar
• D'Angelo A, Kluft C, Verheijen JH, et al. Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor. Eur J Clin Invest. 1985;15(6):308–312.
   PubMed Web of Science ®Google Scholar
• Eriksson BI, Eriksson E, Gyzander E, et al. Thrombosis after hip replacement: relationship to the fibrinolytic system. Acta Orthop Scand. 1989;60(2):159–163.
   PubMed Web of Science ®Google Scholar
• Kluft C, Verheijen JH, Jie AFH, et al. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest. 1985;45(7):605–610.
   PubMed Web of Science ®Google Scholar
• Undas A, Ariëns RAS. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol. 2011;31:e88–99.
   PubMed Web of Science ®Google Scholar
• Dunn EJ, Ariëns RAS, Grant PJ. The influence of type 2 diabetes on fibrin structure and function. Diabetologia. 2005;48(6):1198–1206.
   PubMed Web of Science ®Google Scholar
• Undas A, Plicner D, Stepień E, et al. Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a) and homocysteine. J Thromb Haemost. 2007;5(9):1988–1990.
   PubMed Web of Science ®Google Scholar
• Kwasny-Krochin B, Gluszko P, Undas A. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis. Thromb Res. 2010;126(1):e11-6–e16.
   PubMed Web of Science ®Google Scholar
• Sidelmann JJ, Gram JB, Godtfredsen ACM, et al. Orthognathic surgery-induced fibrinolytic shutdown is amplified by tranexamic acid. J Oral Maxillofac Surg. 2020;78(7):1183–1189.
   PubMed Web of Science ®Google Scholar
• Lee KW, Lip GYH. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med. 2003;163(19):2368–2392.
   PubMedGoogle Scholar
• Devereaux PJ, Duceppe E, Guyatt G, et al. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet. 2018;391(10137):2325–2334.
   PubMed Web of Science ®Google Scholar